News

Symrise appoints new CFO

Symrise has appointed Olaf Klinger to become Chief Financial Officer (CFO) of the company. He will join from private clinic operator AMEOS, where, as a managing executive, he is in charge of the finance department. Before that, he held various management positions during his many years at Merck KGaA. On February 1, 2016, he will […]

Symrise has appointed Olaf Klinger to become Chief Financial Officer (CFO) of the company. He will join from private clinic operator AMEOS, where, as a managing executive, he is in charge of the finance department. Before that, he held various management positions during his many years at Merck KGaA. On February 1, 2016, he will take over the finance department at Symrise, thereby succeeding Bernd Hirsch. As announced in March 2015, Hirsch is leaving at his own request and on amicable terms at the end of the year.

According to Symrise, Klinger has over 20 years of experience in corporate finance and also brings with him substantial expertise in the chemical and healthcare sectors. He was employed for over twelve years by pharmaceutical and chemical company Merck in Darmstadt and acted as CFO for the Swiss subsidiary Merck Serono in Geneva. He held management positions in controlling, accounting, corporate finance, treasury and investor relations. He also led the introduction of the global financial organisation of Merck, which he most recently headed.

“We are very pleased to have won Olaf Klinger as new CFO. He brings with him extensive expertise in this field and has a high degree of sector-specific know-how in Symrise’s areas of growth,” said Dr. Thomas Rabe, Chairman of the Supervisory Board of Symrise. “He also has years of experience abroad and is thus an excellent addition to Symrise as a growth-oriented, globally active company. We are looking forward to seeing him get off to a good start at Symrise, and, at the same time, would like to thank Bernd Hirsch for all his excellent work over the past six years.”